Planned first efficacy and safety analysis of de-intensified induction with fludarabine, cyclophosphamide plus rituximab (FCR) followed by fludarabine plus rituximab (FR) and remission maintenance therapy with rituximab in previously untreated B-chronic lymphocytic leukemia (B-CLL): The chairos study

Egle, A; Weiss, L; Russ, G; Thoedtmann, R; Pleyer, L; Gastl, G; Thaler, J; Petzer, A; Tinhofer, I; Greil, R BLOOD. 2007; 110(11): 609A-609A.

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukaemia but can be preferentially targeted by the MDM2 inhibitor Nutlin-3a

Tinhofer, I; Gryshchenko, I; Stoecher, M; Hofbauer, S; Daniel, PT; Greil, R EJC SUPPL. 2007; 5(4): 347-347.

Incidence and other aspects of myelodysplastic syndrome in the Austrian federal state Salzburg

Kemmerling, R; Neuretter, D; Faber, V; Stocher, M; Greil, R; Dietze, O PATHOL RES PRACT. 2007; 203(5): 392-392.

Recovery of Renal Impairment by Bortezomib-Doxorubicin-Dexamethasone (BDD) in Multiple Myeloma (MM) Patients with Acute Renal Failure. Results from an Ongoing Phase II Study.

Ludwig, H; Adam, Z; Hajek, R; Greil, R; Keil, F; Zojer, N; Thaler, J; Gisslinger, H; Lang, A; Blood. 2007; 110: 3603–49th Annual Meeting of American Society of Hematology (ASH); 08.-11.12.2007; Atlanta, Georgia.

Follikuläres Lymphom.

Egle, A; In: Greil, R (Ed.) editors(s). Lymphoproliferative Erkrankungen.. p. 93-107.

Morbus Hodgkin.

Greil, R; In: Greil, R (Ed.) editors(s). Lymphoproliferative Erkrankungen..

Regulation of apoptosis.

Pleyer, L; Tinhofer, I; Greil, R; In: Hakan Mellstedt DSDBRG (Ed.) editors(s). ESMO Handbook of principles of translational Research.. p. 67-69.

Entwicklungen und Perspektiven in der Behandlung der Lymphatischen Neoplasien.

Pleyer, L; Desch, P; Greil, R; In: Greil, R (Ed.) editors(s). Lymphoproliferative Erkrankungen.. p. 139-155.

Phase II double-blind randomized trial of daily oral RAD001 (everolimus) plus letrozole (LET) or placebo (P) plus LET as neoadjuvant therapy for ER plus breast cancer_x000D_

Baselga, J; Semiglazov, V; Van Dam, P; Manikhas, A; Bellet, M; Mayordomo, J; Campone, M; Kubista, E; Greil, R; Bianchi, G; Steinseifer, J; Molloy, B; Tokaji, E; Dixon, JM; Jonat, W; Rugo, HS; BREAST CANCER RESEARCH AND TREATMENT_x000D_ . 2007. 106: 107-107.

Lapatinib and capecitabine for the treatment of brain metastases in patients with HER2+ breast cancer-an updated analysis from EGF105084._x000D_

Lin, NU; Paul, D; Dieras, V; Liu, M; Greil, R; Roche, H; Rubin, SD; Zembryki, D; Oliva, C; Jayawardene, D; Winer, EP; Breast cancer research and treatment_x000D_ . 2007. 106: 272-273.